반응식
Cl[C:2]1[N:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[C:9]([F:15])([F:14])[CH2:8][N:7]([CH:16]([CH3:18])[CH3:17])[C:6]=2[N:19]=1.[NH2:20][C:21]1[CH:29]=[CH:28][C:24]([C:25]([OH:27])=[O:26])=[CH:23][C:22]=1[O:30][CH3:31]>C(O)C.O.Cl>[F:14][C:9]1([F:15])[CH2:8][N:7]([CH:16]([CH3:18])[CH3:17])[C:6]2[N:19]=[C:2]([NH:20][C:21]3[CH:29]=[CH:28][C:24]([C:25]([OH:27])=[O:26])=[CH:23][C:22]=3[O:30][CH3:31])[N:3]=[CH:4][C:5]=2[N:11]([CH3:12])[C:10]1=[O:13]참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
A mixture of 0.5 g (0.0017 mole) of 2-chloro-7,7-difluoro-9-isopropyl-5-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-292b) and 0.35 g (0.002 mole) of 4-amino-3-methoxy-benzoic acid in 20 mL of ethanol-water-hydrochloric acid (20:80:1) was refluxed for 18 hours, then cooled and partially concentrated under reduced pressure. The resulting solid was collected by filtration, washed with 0.5M hydrochloric acid and water and dried to give 0.40 g of 4-(7,7-difluoro-9-isopropyl-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoic acid (I-292).
후처리
- temperaturewas refluxed for 18 hours
- temperaturecooled
- concentrationpartially concentrated under reduced pressure
- filtrationThe resulting solid was collected by filtration
- washwashed with 0.5M hydrochloric acid and water
- customdried
출처 및 근거
- ORD 기록
- ord-de0c618d28ef401b971d2e117d7e0c4e
- 출처 데이터셋
- uspto-grants-2011_08
- 특허 번호
- US08003785B2
연결된 노트
불러오는 중…